BRIDGEWAY CAPITAL MANAGEMENT, LLC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 73 filers reported holding KALA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$242,000
-58.2%
175,000
+11.5%
0.01%
-37.5%
Q4 2019$579,000
-3.0%
156,9000.0%0.01%0.0%
Q3 2019$597,000
-32.2%
156,900
+13.7%
0.01%
-27.3%
Q2 2019$880,000
-22.9%
138,0000.0%0.01%
-21.4%
Q1 2019$1,141,000
+174.3%
138,000
+62.4%
0.01%
+133.3%
Q4 2018$416,000
-50.4%
85,0000.0%0.01%
-25.0%
Q3 2018$839,00085,0000.01%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 181,384$54,0000.23%
Samsara BioCapital, LLC 601,162$180,0000.05%
Board of Trustees of The Leland Stanford Junior University 688,701$207,0000.01%
Matisse Capital 36,800$11,0000.01%
Knights of Columbus Asset Advisors LLC 120,841$36,0000.00%
Covestor Ltd 11,972$4,0000.00%
Ergoteles LLC 219,461$66,0000.00%
Virtu Financial LLC 74,636$22,0000.00%
IPG Investment Advisors LLC 14,300$4,0000.00%
Aquatic Capital Management LLC 13,200$4,0000.00%
View complete list of KALA PHARMACEUTICALS INC shareholders